Farmacule will consider moving toward an initial public offer (IPO) to raise additional development capital within two years.

The timing of Farmacule's approach to the market will depend on external factors such as market sentiment and economic conditions.

Capital raising will become important to accelerate Farmacule's R&D Program, fund the development of a processing facility to extract molecules from plants as Farmacule works toward commericialisation, technology licensing and to fund our marketing and sales operations.